Celgene shareholders, rejoice — you’ve been given a way out, analysts say
January 03, 2019 at 14:30 PM EST
Most analysts on Thursday can agree on one thing: Bristol-Myers Squibb Co.’s agreement to acquire Celgene Corp. is a win for Celgene’s shareholders.
